期刊文献+

肝纤维化大鼠肝脏ACE/ACE2的动态变化 被引量:1

下载PDF
导出
摘要 目的研究肝纤维化进程中大鼠肝脏血管紧张素转换酶(ACE)、血管紧张素转换酶(2ACE 2)水平及ACE/ACE 2的动态变化。方法制备四氯化碳(CCl4)诱导大鼠肝纤维化模型,分别于造模第15、30、45、60天处死模型组大鼠各6只,各组大鼠肝组织行HE和Masson染色,Western blot法检测肝组织匀浆ACE、ACE2蛋白表达。结果在大鼠肝纤维化过程中,肝组织ACE、ACE 2水平呈上升趋势;第15、30天模型组ACE/ACE 2比值较对照组降低(P<0.05),而第45天模型组其比值高于对照组(P<0.05),第60天时该比值明显增高(P<0.01)。结论 ACE、ACE 2均参与大鼠肝纤维化形成。 Objective To explore variation on level of angiotensin converting enzyme(ACE) and angiotensin converting enzyme 2(ACE 2), ratio of ACE/ACE 2 in hepatic fibrosis in rats. Methods Except rats in control group,all were given subcutaneous injection of 40% CC14. Each 6 rats in the model group were killed at 15, 30, 45 and 60 day respectively. Histopathological study of liver tissue was done with hematoxylin-eosin(HE)and Masson trichrome staining.ACE arid ACE 2 levels were determined by Western blot analysis. Results The level of ACE and ACE 2 show ascendant trend during fibrosis rats, ACE^ACE 2 ratio of model group at 15, 30 day reduced than control group. Conclusion The occurrence and development of hepatic fibrosis are possibly associated with imbalances between ACE and ACE 2.
出处 《当代医学》 2013年第28期22-24,共3页 Contemporary Medicine
关键词 肝纤维化 血管紧张素转换酶 血管紧张素转换酶2 Hepatic fibrosis ACE ACE 2
  • 相关文献

参考文献5

二级参考文献116

  • 1Silvia Sookoian,María Alejandra Fernández,Gustavo Casta(n|~)o.Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: A pilot study[J].World Journal of Gastroenterology,2005,11(48):7560-7563. 被引量:7
  • 2Bataller R, Gabele E, Parsons CJ, Morris T, Yang L, Schoonhoven R, Brenner DA, Rippe RA. Systemic hafusion of angiotensin Ⅱ exacerbates liver fibrosis in bile ductligated rats. Hepatology 2005; 41:1046-1055. 被引量:1
  • 3Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther 2001; 89:221-231. 被引量:1
  • 4Mezzano SA, Ruiz-Ortega M, Egido J. Angiotensin Ⅱ and renal fibrosis. Hypertension 2001; 38:635-638. 被引量:1
  • 5Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin Ⅱ blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 2002; 13: 2464-2477. 被引量:1
  • 6Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin If-mediated cardiovascular and renal diseases. Pharmacol Rev 2000; 52:11-34. 被引量:1
  • 7Yu L, Noble NA, Border WA. Therapeutic strategies to halt renal fibrosis. Curr Opin Pharmacol 2002; 2:177-181. 被引量:1
  • 8Burdmann EA, Andoh TF, Nast CC, Evan A, Connors BA, Coffman TM, Lindsley J, Bennett WM. Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril. Am J Physiol 1995; 269:F491-F499. 被引量:1
  • 9Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994; 45:1637-1647. 被引量:1
  • 10Brenner DA, Westwick J, Breindl M. Type Ⅰ collagen gene regulation and the molecular pathogenesis of cirrhosis. Am J Physiol 1993; 264:G589-G595. 被引量:1

共引文献55

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部